A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CRi

Search Conditions:
Search Keyword : CRi
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: CRi
Appearance Frequency: 64 time(s)
Long forms: 18

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
complete remission with incomplete count recovery
(21 times)
Hematology
(11 times)
CR (16 times)
AML (13 times)
OS (6 times)
2012 A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia.
CR with incomplete hematologic recovery
(15 times)
Hematology
(9 times)
CR (15 times)
AML (8 times)
ALL (3 times)
2013 High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
cerebral resistance index
(7 times)
Obstetrics
(4 times)
URI (2 times)
C/U (1 time)
CEA (1 time)
1984 The effect of exogenous hormones on the resistance of the early pregnant human cervix.
CR with incomplete marrow recovery
(4 times)
Hematology
(2 times)
CR (4 times)
CLL (2 times)
AGMT (1 time)
2015 Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial.
CR with incomplete ANC and PLT recovery
(2 times)
Hematology
(2 times)
AML (2 times)
CRp (2 times)
CIR (1 time)
2017 [Prognostic significance of blood count at the time of achieving morphologic leukemia-free state in adults with acute myeloid leukemia].
CR with incomplete recovery
(2 times)
Neoplasms
(2 times)
AML (2 times)
CR (2 times)
GO (1 time)
2012 Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia.
CR with incomplete recovery of blood cells
(2 times)
Hematology
(2 times)
CR (2 times)
allo-HSCT (1 time)
CRS (1 time)
2014 [Imatinib in combination with allogeneic hematopoietic stem cell transplantation improved the outcome of adult Philadelphia chromosome-positive acute lymphoblastic leukemia].
center of rotation
(1 time)
Physiology
(1 time)
--- 1994 Optimal marker placement for calculating the instantaneous center of rotation.
cerebral resistance
(1 time)
Medicine
(1 time)
--- 1992 Pathophysiology of unilateral high-grade carotid artery stenosis: evaluation of intracranial haemodynamics by analysis of velocity waveforms from the middle cerebral artery.
10  complete response with incomplete neutrophil and platelet recovery
(1 time)
Neoplasms
(1 time)
CR (1 time)
CRp (1 time)
DLT (1 time)
2016 A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
11  CR with incomplete blood count recovery
(1 time)
Hematology
(1 time)
AML (1 time)
EFS (1 time)
G-CSF (1 time)
2013 Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.
12  CR with insufficient recovery of blood counts
(1 time)
Hematology
(1 time)
AML (1 time)
CR (1 time)
2012 Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
13  CR without recovery of counts
(1 time)
Neoplasms
(1 time)
ALL (1 time)
CR (1 time)
CRp (1 time)
2015 A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
14  CR, three of which were incomplete
(1 time)
Hematology
(1 time)
AML (1 time)
CR (1 time)
GO (1 time)
2008 Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial.
15  CRs with incomplete recovery of neutrophils or platelets
(1 time)
Neoplasms
(1 time)
AML (1 time)
CR (1 time)
LDAC (1 time)
2013 Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia.
16  CR + complete remission with incomplete white blood cell recovery
(1 time)
Neoplasms
(1 time)
AML (1 time)
CR (1 time)
LDAC (1 time)
2019 Efficacy outcomes in the treatment of older or medically unfit patients with acute myeloid leukaemia: A systematic review and meta-analysis.
17  curvature radius
(1 time)
General Surgery
(1 time)
CT (1 time)
TI (1 time)
2017 MorphologicalAnalysis of Healthy Aortic Arch.
18  cycle.Three patients achieved incomplete remission
(1 time)
Internal Medicine
(1 time)
AML (1 time)
IL-2 (1 time)
ORR (1 time)
2016 [Thalidomide combined with interferon and interleukin-2 in treatment of relapsed or refractory acute myelogenous leukemia].